Céline Dion is gearing up for her upcoming five-week residency in Paris, set to kick off next month, as she shares more insights into her health battle and treatment journey. Disclosing in an exclusive profile by Harper’s Bazaar, the Canadian music icon revealed her struggle with stiff person syndrome for 17 years before receiving a formal diagnosis in 2022.
The onset of severe pain in 2020 left Dion sometimes struggling to walk and requiring a high dosage of Valium to manage. Stiff person syndrome, a rare neurological autoimmune disorder affecting approximately one or two individuals per million, is a progressive condition characterized by rigid muscles and painful spasms triggered by stress, loud noises, or sudden movements. Despite the absence of a specific approved treatment, various therapies can assist in symptom management.
Prior to her diagnosis, Dion often attributed show cancellations to minor ailments like coughs or sinus infections, concealing the true extent of her suffering. Feeling a sense of dishonesty towards her fans, whose unwavering support enabled her to seek extensive treatment, Dion decided to cancel all remaining shows following her diagnosis. While she hasn’t performed publicly since the 2024 Paris Olympics, she is poised to make a comeback in September.
Dion’s determined recovery regimen involves a combination of medication, physical therapy, vocal therapy, and immunotherapy. Additionally, she engages in rigorous 90-minute Pilates sessions thrice weekly and ballet classes twice a week to prepare for her forthcoming performances. Described as being in constant motion and wary of becoming immobile again, Dion views her recovery and return to the stage as nothing short of a miracle, expressing gratitude for the opportunity to perform once more.
Feeling strong, excited, and slightly apprehensive but eager to return, Dion is set to grace the stage in Paris for a 26-concert residency running from September 12 to May 29 next year.